New hope for cancer patients losing too much weight
NCT ID NCT07477808
Summary
This study is testing whether adding a medication called megestrol acetate to standard lung cancer treatment helps malnourished patients gain weight and improve their appetite. Researchers will compare weight gain, appetite, and cancer treatment outcomes between patients receiving the standard treatment alone versus the standard treatment plus megestrol. The trial will enroll about 116 adults with advanced non-small cell lung cancer who have not had previous treatment for their advanced disease and have a low body mass index.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.